Cargando…

Inhibition properties of free and conjugated leupeptin analogues

Leupeptin is a naturally occurring inhibitor of various proteases, in particular serine proteases. Following its discovery, the inhibitory properties of several other peptidyl argininals have been studied. The specificity of leupeptin is most likely due to the Leu–Leu–Argininal sequence, and its C‐t...

Descripción completa

Detalles Bibliográficos
Autores principales: Billinger, Erika, Viljanen, Johan, Lind, Sara Bergström, Johansson, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714073/
https://www.ncbi.nlm.nih.gov/pubmed/33016476
http://dx.doi.org/10.1002/2211-5463.12994
_version_ 1783618676126121984
author Billinger, Erika
Viljanen, Johan
Lind, Sara Bergström
Johansson, Gunnar
author_facet Billinger, Erika
Viljanen, Johan
Lind, Sara Bergström
Johansson, Gunnar
author_sort Billinger, Erika
collection PubMed
description Leupeptin is a naturally occurring inhibitor of various proteases, in particular serine proteases. Following its discovery, the inhibitory properties of several other peptidyl argininals have been studied. The specificity of leupeptin is most likely due to the Leu–Leu–Argininal sequence, and its C‐terminal aldehyde group has been suggested to enhance the binding efficiency and to be essential for function. The terminal aldehyde group makes the structure less vulnerable to carboxypeptidases. Here, we investigated whether the inhibitory function of leupeptin toward serine proteases is retained after oxidation or reduction of the aldehyde group. The oxidized form, which corresponds to the natural precursor, was shown to be superior to the reduced form in terms of inhibitory properties. However, the original leupeptin possessed enhanced inhibitory properties as compared with the oxidized form. Based on these results, new synthetic leupeptin analogues, 6‐aminohexanoic acid (Ahx)–Phe–Leu–Arg–COOH and Ahx–Leu–Leu–Arg–COOH, were prepared by solid‐phase peptide synthesis using the Fmoc strategy. In these analogues, the N‐terminal capping acetyl group was replaced with a 6‐aminohexanoyl group to allow conjugation. The structures of the modified leupeptin and the synthetic peptides were confirmed by mass spectrometry. Determination of the inhibitory properties against trypsin (IEC 3.4.21.4, Chymotrypsin IEC 3.4.21.1) revealed that these further modified tripeptides were tight binding inhibitors to their target enzyme, similar to the naturally occurring leupeptin, with K(i) values generally in the micromolar range. The Ahx–Phe–Leu–Arg–COOH analogue was selected for conjugation to inorganic oxide nanoparticles and agarose gel beads. All conjugates exhibited inhibitory activity in the same range as for the free peptides.
format Online
Article
Text
id pubmed-7714073
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77140732020-12-09 Inhibition properties of free and conjugated leupeptin analogues Billinger, Erika Viljanen, Johan Lind, Sara Bergström Johansson, Gunnar FEBS Open Bio Research Articles Leupeptin is a naturally occurring inhibitor of various proteases, in particular serine proteases. Following its discovery, the inhibitory properties of several other peptidyl argininals have been studied. The specificity of leupeptin is most likely due to the Leu–Leu–Argininal sequence, and its C‐terminal aldehyde group has been suggested to enhance the binding efficiency and to be essential for function. The terminal aldehyde group makes the structure less vulnerable to carboxypeptidases. Here, we investigated whether the inhibitory function of leupeptin toward serine proteases is retained after oxidation or reduction of the aldehyde group. The oxidized form, which corresponds to the natural precursor, was shown to be superior to the reduced form in terms of inhibitory properties. However, the original leupeptin possessed enhanced inhibitory properties as compared with the oxidized form. Based on these results, new synthetic leupeptin analogues, 6‐aminohexanoic acid (Ahx)–Phe–Leu–Arg–COOH and Ahx–Leu–Leu–Arg–COOH, were prepared by solid‐phase peptide synthesis using the Fmoc strategy. In these analogues, the N‐terminal capping acetyl group was replaced with a 6‐aminohexanoyl group to allow conjugation. The structures of the modified leupeptin and the synthetic peptides were confirmed by mass spectrometry. Determination of the inhibitory properties against trypsin (IEC 3.4.21.4, Chymotrypsin IEC 3.4.21.1) revealed that these further modified tripeptides were tight binding inhibitors to their target enzyme, similar to the naturally occurring leupeptin, with K(i) values generally in the micromolar range. The Ahx–Phe–Leu–Arg–COOH analogue was selected for conjugation to inorganic oxide nanoparticles and agarose gel beads. All conjugates exhibited inhibitory activity in the same range as for the free peptides. John Wiley and Sons Inc. 2020-11-02 /pmc/articles/PMC7714073/ /pubmed/33016476 http://dx.doi.org/10.1002/2211-5463.12994 Text en © 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Billinger, Erika
Viljanen, Johan
Lind, Sara Bergström
Johansson, Gunnar
Inhibition properties of free and conjugated leupeptin analogues
title Inhibition properties of free and conjugated leupeptin analogues
title_full Inhibition properties of free and conjugated leupeptin analogues
title_fullStr Inhibition properties of free and conjugated leupeptin analogues
title_full_unstemmed Inhibition properties of free and conjugated leupeptin analogues
title_short Inhibition properties of free and conjugated leupeptin analogues
title_sort inhibition properties of free and conjugated leupeptin analogues
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714073/
https://www.ncbi.nlm.nih.gov/pubmed/33016476
http://dx.doi.org/10.1002/2211-5463.12994
work_keys_str_mv AT billingererika inhibitionpropertiesoffreeandconjugatedleupeptinanalogues
AT viljanenjohan inhibitionpropertiesoffreeandconjugatedleupeptinanalogues
AT lindsarabergstrom inhibitionpropertiesoffreeandconjugatedleupeptinanalogues
AT johanssongunnar inhibitionpropertiesoffreeandconjugatedleupeptinanalogues